Back to User profile » Dr Shoko Kawai
Paper published by Dr Shoko Kawai:
Case report
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Ceritinib for an anaplastic lymphoma kinase rearrangement-positive patient previously treated with alectinib with poor performance status
![](cr_data/cache/submission_images/s186000/186213/17_dec_2018_186213_fig1_200_200_90.jpg)
Kitadai R, Okuma Y, Kawai S
OncoTargets and Therapy 2019, 12:15-19
Published Date: 17 December 2018